skip to main content
Idioma:

Access to treatment for phenylketonuria by judicial means in Rio Grande do Sul, Brazil/Acesso ao tratamento para fenilcetonuria por via judicial no Rio Grande do Sul, Brasil

Trevisan, Luciano Mangueira ; Nalin, Tatiele ; Tonon, Tassia ; Veiga, Lauren Monteiro ; Vargas, Paula ; Krug, Barbara Correa ; Leivas, Paulo Gilberto Cogo ; Schwartz, Ida Vanessa Doederlein

Ciência & saude coletiva, 2015-05, Vol.20 (5), p.1607 [Periódico revisado por pares]

Associacao Brasileira de Pos-Graduacao em Saude Coletiva - ABRASCO

Texto completo disponível

Citações Citado por
  • Título:
    Access to treatment for phenylketonuria by judicial means in Rio Grande do Sul, Brazil/Acesso ao tratamento para fenilcetonuria por via judicial no Rio Grande do Sul, Brasil
  • Autor: Trevisan, Luciano Mangueira ; Nalin, Tatiele ; Tonon, Tassia ; Veiga, Lauren Monteiro ; Vargas, Paula ; Krug, Barbara Correa ; Leivas, Paulo Gilberto Cogo ; Schwartz, Ida Vanessa Doederlein
  • É parte de: Ciência & saude coletiva, 2015-05, Vol.20 (5), p.1607
  • Descrição: Treatment of phenylketonuria (PKU) includes the use of a metabolic formula which should be provided free of charge by the Unified Health System (SUS). This retrospective, observational study sought to characterize judicial channels to obtain PKU treatment in Rio Grande do Sul (RS), Brazil. Lawsuits filed between 20012010 and having as beneficiaries PKU patients requesting treatment for the disease were included. Of 20 lawsuits filed, corresponding to 16.8% of RS patients with PKU, 19 were retrieved for analysis. Of these, only two sought to obtain therapies other than metabolic formula. In all the other 17 cases, prior treatment requests had been granted by the State Department of Health. Defendants included the State (n = 19), the Union (n = 1), and municipalities (n = 4). In 18/19 cases, the courts ruled in favor of the plaintiffs. Violation of the right to health and discontinuation of State-provided treatment were the main reasons for judicial recourse. Unlike other genetic diseases, patients with PKU seek legal remedy to obtain a product already covered by the national pharmaceutical assistance policy, suggesting that management failures are a driving factor for judicialization in Brazil.
  • Editor: Associacao Brasileira de Pos-Graduacao em Saude Coletiva - ABRASCO
  • Idioma: Espanhol
Voltar para lista de resultados

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.